INS and schizophrenia: Our research, akin to the findings of Pavlović et al. and Pillinger et al., reveals elevated levels of glucose and various metabolic parameters in schizophrenia patients, including insulin, the HOMA-IR index, uric acid, and triglycerides when compared to the control group.